pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Dermatology · news · pharmadog
← back to Dermatology
News · Dermatology
226
stories
Sep 3, 26
Psilocybin proves promising in neuropathic pain mouse study
fiercebiotech
Sep 2, 26
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
biopharma dive
Sep 2, 26
Teva autoimmune antibody notches ph. 2 win in celiac disease
fiercebiotech
Sep 1, 26
Novartis says MS pill succeeds in two large studies
biopharma dive
Aug 31, 26
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
biospace
Aug 31, 26
China poses increasing security risk as US biotech innovation edge erodes
biospace
Aug 31, 26
Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
fda medwatch
Aug 28, 26
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
fda press
Aug 28, 26
FDA green lights Priovant drug for rare skin disease
biopharma dive
Aug 28, 26
STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more
stat
Aug 28, 26
Priovant nabs first FDA approval for targeted tablet in dermatomyositis
biospace
Aug 28, 26
Early Alert: IV Start Kit Issue from Avid Medical
fda medwatch
Aug 27, 26
STAT+: FDA approves Roivant therapy for rare autoimmune disease
stat
Aug 27, 26
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
fda press
Aug 27, 26
Michael Polansky has a new, skin-focused biotech. Don’t call it a drug company.
biopharma dive
Aug 27, 26
What’s in Merck and Moderna’s cancer vaccine algorithm?
stat
Aug 27, 26
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
fiercebiotech
Aug 25, 26
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
fda press
Aug 25, 26
With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
fiercebiotech
Aug 24, 26
Early Alert: Convenience Kit Issue from AVID Medical
fda medwatch
Aug 24, 26
Early Alert: Convenience Kit Issue from Medline
fda medwatch
Aug 20, 26
STAT+: How health systems are embracing chatbots to query and summarize patient records
stat
Aug 19, 26
FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device
fda press
Aug 19, 26
11 companies hiring in New Jersey
biospace
Aug 18, 26
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
fiercebiotech
Aug 18, 26
Leo Pharma buys rare skin disease drug in $435M deal
biopharma dive
Aug 18, 26
LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
biospace
Aug 18, 26
Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure
endpoints
Aug 17, 26
Argenx jumps on Phase 3 data for blockbuster Vyvgart
biopharma dive
Aug 17, 26
Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod
fiercebiotech
← prev
page 4 of 8
next →